Search SciPol

Brought to you by
March 1, 2018 8:00 am - March 1, 2018 6:00 pm

Meeting: FDA Neurological Devices Panel of the Medical Devices Advisory Committee

  • Government
  • Agency
  • Science
  • Nanotechnology
  • Neuroscience

The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Neurological Devices Panel of the Medical Devices Advisory Committee. The general function of the committee is to provide advice and recommendations to the Agency on FDA's regulatory issues. 

The committee will discuss, make recommendations, and advise FDA regarding the evaluation of clinical study data to support the safety and effectiveness of intracranial aneurysm treatment devices and factors that can affect clinical outcomes such as aneurysm morphology, size, and location in the neurovasculature. FDA is also convening this committee to seek expert opinion on the scientific and clinical considerations relating to the clinical trial design that may be relevant to the determination of safety and effectiveness for these devices.

Members of the public may attend in person. More information is available via the Federal Register notice.